Shelter Pharma has successfully completed the manufacturing of an export order worth USD 141,600 for Joemega Capsules and commenced dispatch to Sudan. The order was secured from Taha Drugs & Chemicals Co. Ltd, with products valued at USD 118,634 already shipped as of June 8, 2026. The balance quantity is being dispatched according to the shipment schedule.

The disclosure was made to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company informed the exchange that the manufacturing process for the order is now complete.

Order Details

The export order involves the supply of Joemega Capsules to Sudan. The total order value stands at USD 141,600, with a significant portion already delivered to the client.

The filing was signed by Mustaqim Nisarahmed Sabugar, Managing Director of Shelter Pharma Limited, on June 8, 2026.

Shelter Pharma has obtained Good Manufacturing Practice (GMP) certification for its Ayurvedic manufacturing plant, with the certification valid until 2030. This regulatory recognition underscores the company's compliance with established quality and manufacturing standards applicable to Ayurvedic pharmaceutical production.

GMP Certification Details

The following table summarizes the key details of the certification:

Significance of the Certification

GMP certification is a critical regulatory requirement for pharmaceutical and Ayurvedic manufacturers, ensuring that products are consistently produced and controlled in accordance with quality standards. The certification for Shelter Pharma's Ayurvedic manufacturing plant confirms that the facility meets the requisite norms set by the relevant regulatory authorities. The validity of the certification extending until 2030 provides the company with a defined operational window under this regulatory approval.